• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine

by Jasmine Pennic 06/19/2018 Leave a Comment

Roche Acquires Rest of Foundational Medicine for $2.4B to Enhance Precision Medicine

Roche, today announced it has acquire all of the outstanding shares in Foundation Medicine that is not already owned by Roche and its affiliates for $2.4B, representing $137 per share. Together, the companies will leverage expertise in genomics and molecular information to enhance the development of perdsonalized medicines and care for patients with cancer.

Foundation Medicine, based in Cambridge, Massachusetts, is a market leading molecular information company dedicated to a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease. Their services include a full suite of comprehensive genomic profiling (CGP) assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials.

Upon closing, the acquisition focuses on integrating Foundation Medicine’s high quality comprehensive genomic profiling (CGP) testing and innovative data services to realise Roche’s vision of personalized healthcare. Foundation Medicine (FMI) will continue its operations as a separate and autonomous legal entity.

“Foundation Medicine and Roche share the philosophy that every cancer patient should have access to personalized care informed by validated molecular information. Joining forces with Roche as an independent operating company allows Foundation Medicine to continue its collaboration with Roche, as well as our biopharma partners, to drive ubiquitous access to CGP testing and innovative data services,” said Troy Cox, Chief Executive Officer for Foundation Medicine.

The acquisition is expected to take place in the second half of 2018.

RELATED:   Modernizing Medicine Acquires Orthopedic EHR Platform Exscribe – M&A

Tagged With: Cancer Genomics, foundational, genomic precision medicine, Healthcare Mergers & Acquisitions, Precision Medicine Oncology, Roche

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Qardio Integrates Remote Monitoring Solution with Greenway Health EHR Solution
Partners Healthcare Taps Circulation to Bring On-Demand Medical Transportation to Patients »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • mPulse Mobile Acquires Digital Health Engagement Company Big Know

    mPulse Mobile Acquires Digital Health Engagement Company The Big Know

    ... more
  • HHS Launches EHR Innovations for Improving Hypertension Challenge_HHS Funded Health Care Innovation Award Projects to Watch

    HHS Awards Funds to Increase Data Sharing Between HIEs & Immunization Registries

    ... more
  • Aledade ACO

    Aledade Secures $100M for Value-Based Primary Care, Reaching $2.1B Valuation

    ... more
  • Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization

    Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization

    ... more

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • Philips Acquires Medical Device Integration Platform Capsule for $635M Philips Acquires Medical Device Integration Platform Capsule for $635M
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 20 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • DPHO, UnitedHealthcare Launch Accountable Care Program UnitedHealth Rolls Out Employer Virtual Primary Care Plan
  • Abbott to Launch App to Track and Report Pain Relief in Chronic Pain Patients Abbott to Launch App to Track and Report Pain Relief in Chronic Pain Patients
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |